Correlation Between Immuron and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immuron and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immuron and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immuron Ltd ADR and Tscan Therapeutics, you can compare the effects of market volatilities on Immuron and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immuron with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immuron and Tscan Therapeutics.

Diversification Opportunities for Immuron and Tscan Therapeutics

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Immuron and Tscan is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Immuron Ltd ADR and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Immuron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immuron Ltd ADR are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Immuron i.e., Immuron and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Immuron and Tscan Therapeutics

Given the investment horizon of 90 days Immuron Ltd ADR is expected to generate 0.86 times more return on investment than Tscan Therapeutics. However, Immuron Ltd ADR is 1.16 times less risky than Tscan Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.23 per unit of risk. If you would invest  188.00  in Immuron Ltd ADR on October 23, 2024 and sell it today you would earn a total of  27.00  from holding Immuron Ltd ADR or generate 14.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Immuron Ltd ADR  vs.  Tscan Therapeutics

 Performance 
       Timeline  
Immuron Ltd ADR 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Immuron Ltd ADR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Immuron displayed solid returns over the last few months and may actually be approaching a breakup point.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Immuron and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immuron and Tscan Therapeutics

The main advantage of trading using opposite Immuron and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immuron position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind Immuron Ltd ADR and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine